36th week of 2010 patent applcation highlights part 32 |
Patent application number | Title | Published |
20100226808 | MULTI STAGE, CLAM SHELL VACUUM PUMP - A multi-stage, clam shell, vacuum pump comprises two housing components ( | 2010-09-09 |
20100226809 | Pivoting vane pump/motor - An improved pivoting vane pump or motor with vane timing that minimizes friction by eliminating contact between the pressurizing vane | 2010-09-09 |
20100226810 | Process for Manufacturing Metal Particles - Metal particles approximately in the form of spheres having a mean diameter of about 40 μm to about 100 μm, including magnesium silicide particles having a mean diameter of about 1 μm to about 10 μm uniformly dispersed in the metal particles, the metal particles being obtained by mixing about 90 wt. % to about 95 wt. % of magnesium and about 5 wt. % to about 10 wt. % of silicon, and the magnesium silicide particles being formed in the metal particles by the reaction of the magnesium and the silicon. | 2010-09-09 |
20100226811 | FEATURE FORMING PROCESS USING PLASMA TREATMENT - A process comprising: (a) forming a feature comprising uncoalesced silver-containing nanoparticles; (b) heating the uncoalesced silver-containing nanoparticles to form coalesced silver-containing nanoparticles; and (c) subjecting to a plasma treatment the uncoalesced silver-containing nanoparticles or the coalesced silver-containing nanoparticles, or both the uncoalesced silver-containing nanoparticles and the coalesced silver-containing nanoparticles, wherein the feature prior to the action (c) exhibits a low electrical conductivity but the electrical conductivity of the feature subsequent to the actions (b) and (c) is increased by at least about 100 times, wherein the action (c) is undertaken during one or more of prior to the heating, or during the heating, or after the heating. | 2010-09-09 |
20100226812 | HIGH-STRENGTH AND HIGH-TOUGHNESS MAGNESIUM BASED ALLOY, DRIVING SYSTEM PART USING THE SAME AND MANUFACTURING METHOD OF HIGH-STRENGTH AND HIGH-TOUGHNESS MAGNESIUM BASED ALLOY MATERIAL - A high-strength and high-toughness magnesium based alloy contains, by weight, 1 to 8% rare earth element and 1 to 6% calcium and the maximum crystal grain diameter of magnesium constituting a matrix is not more than 30 μm. At least one intermetallic compound ( | 2010-09-09 |
20100226813 | HIGH TENSILE STRENGTH STEEL AND MARINE STRUCTURE HAVING EXCELLENT WELD TOUGHNESS - In order to provide a high tensile strength steel having excellent low temperature toughness and which can withstand large heat input welding, a steel comprises, in mass percent, C: 0.01-0.10%, Si: at most 0.5%, Mn: 0.8-1.8%, P: at most 0.020%, S: at most 0.01%, Cu: 0.8-1.5%, Ni: 0.2-1.5%, Al: 0.001-0.05%, N: 0.0030-0.0080%, O: 0.0005-0.0035%, if necessary at least one of Ti: 0.005-0.03%, Nb: 0.003-0.03%, and Mo: 0.1-0.8%, and a remainder of Fe and impurities, and the N/Al ratio is 0.3-3.0. | 2010-09-09 |
20100226814 | LOW-THERMAL-EXPANSION NI-BASED SUPER-HEAT-RESISTANT ALLOY FOR BOILER AND HAVING EXCELLENT HIGH-TEMPERATURE STRENGTH, AND BOILER COMPONENT AND BOILER COMPONENT PRODUCTION METHOD USING THE SAME - Disclosed is a low-thermal-expansion Ni-based super-heat-resistant alloy for a boiler, which has excellent high-temperature strength. The alloy can be welded without the need of carrying out any aging treatment. The alloy has a Vickers hardness value of 240 or less. The alloy comprises (by mass) C in an amount of 0.2% or less, Si in an amount of 0.5% or less, Mn in an amount of 0.5% or less, Cr in an amount of 10 to 24%, one or both of Mo and W in such an amount satisfying the following formula: Mo+0.5 W=5 to 17%, Al in an amount of 0.5 to 2.0%, Ti in an amount of 1.0 to 3.0%, Fe in an amount of 10% or less, and one or both of B and Zr in an amount of 0.02% or less (excluding 0%) for B and in an amount of 0.2% or less (excluding 0%) for Zr, with the remainder being 48 to 78% of Ni and unavoidable impurities. | 2010-09-09 |
20100226815 | Lead-Free Brass Alloy - The invention relates to brass alloys that are substantially lead-free. In the alloys of the invention, lead is replaced with tellurium resulting in alloys that exhibit excellent machinability and conductivity. | 2010-09-09 |
20100226816 | GOLD ALLOY WIRE FOR BALL BONDING - There is provided a gold alloy wire for a ball bonding. The gold alloy consists of 10 to 50 ppm by mass of magnesium (Mg); 5 to 20 ppm by mass of europium (Eu); 2 to 9 ppm by mass of calcium (Ca); and a remaining portion being gold (Au) having a purity of a minimum of 99.998% by mass. In the gold alloy wire for a ball bonding, an addition amount of calcium (Ca) is a maximum of half that of europium (Eu). | 2010-09-09 |
20100226817 | HIGH STRENGTH L12 ALUMINUM ALLOYS PRODUCED BY CRYOMILLING - A method and apparatus produces high strength aluminum alloys from a cryomilled powder containing L1 | 2010-09-09 |
20100226818 | MULTIPLE-FUNCTION DEODORANT DISPENSER APPARATUS AND METHODS - A multiple-purpose deodorant dispenser unit is provided, comprising: (a) first apparatus adapted for alternatively receiving (i) an aerosol spray deodorant container, (ii) an open deodorant container having gel, liquid or solid deodorant therein, or (iii) a wick cylinder having deodorant therein; (b) second apparatus adjacent to the first apparatus adapted for alternatively containing (i) a spray actuating head device for activating a nozzle in the aerosol spray deodorant container to emit a spray of vaporized deodorant, or (ii) a fan head device for directing a movement of air in the vicinity of either the open container or the wick cylinder; and (c) a third apparatus having electrical means for alternatively operating the spray actuating head device or the fan head device. | 2010-09-09 |
20100226819 | Descenting systems and methods - The present invention, in certain aspects, discloses systems and methods for treating a human being and/or items with descenting material, the systems, in certain aspects, including a generator for producing descenting material, and, in certain aspects at least one direction apparatus in communication with the generator for receiving produced descenting material from the generator and for directing said descenting material in a desired direction. | 2010-09-09 |
20100226820 | Sterile Polymerizable Systems And Kits And Methods Of Their Manufacture And Use - The present invention overcomes the difficulties in the sterilization and delivery of viscous, multi-component compositions that require pre-mixing prior to usage by disclosing a sterile, multi-component, ready-to-use product wherein each component is sterilized independently and then assembled into a sterilized delivery kit. In certain preferred embodiments of the present invention, a sterile, polymerizable system is provided that comprises a plurality of sterile polymerizable monomers, said monomers having been sterilized by passing them through a filter; at least one sterile filler which has been exposed to conditions effective to render said filler sterile, and the sterile monomers and the sterile filler being blended together to form at least one substantially homogeneous blend contained within a sterile delivery vessel. Still other embodiments include a single-use kit that comprises a delivery gun, mix tips, and cartridges that comprise one or more pastes of the present invention that are housed within one or more pouches to ensure sterility of the internal contents. | 2010-09-09 |
20100226821 | Methods and Apparatuses for the Disinfection of Objects, Devices and Areas - A method and apparatus for the sanitization, detoxification, disinfection, high level disinfection, or sterilization of both the interior and exterior surfaces of an object or plurality of objects, including those with lumens and/or channels of various sizes, within a closed space, or closed system of space, in addition to their surrounding atmosphere, and relates particularly, though not exclusively, to the generation of an aerosol including an anti-pathogen/toxin/fungal/sporicidal agent(s) or substance(s)(applied agent), or chemical neutralizing agent(s) or substance(s), by way of one or more ultrasonic nebulizer(s). However the applied agent used in the present invention may also be in the form of any gas, vapor, plasma, aerosol, or other form. The said apparatus and method also includes an option to incorporate and utilize a means to wash the object(s) or endoscope(s). More importantly, the present invention addresses an improvement to the current art, by a new method and apparatus for the application of a positive or negative air/gas pressure to the internal space, lumens, ducts, or channels, of an object or endoscope, in order to apply or administer applied agent, in the form of a gas, plasma, vapor, or aerosol to the surfaces within these locations as well as to the surfaces and areas that interface with the means to apply the positive or negative air/gas pressure to the object or endoscope. The present invention addresses the current problem of obtaining full sanitization, disinfection, high level disinfection, or sterilization, of both the interior and exterior surfaces and areas of an object or endoscope as well as the interfacing surfaces and areas between the applicator for the applied agent and the object or endoscope. The present invention will allow for the complete sanitization, disinfection, high level disinfection, or sterilization of objects in a simple chamber, or in more complex configurations that include, but are not limited to, glove box units, processors with built in interfaces for specialty applications such as endoscope reprocessing, and other application specific designs. | 2010-09-09 |
20100226822 | Mechanical cartridge with test strip fluid control features for use in a fluid analyte meter - A structure for controlling fluid flow from a sample receiving pad into a lateral flow assay test strip, including: a lateral flow assay test strip; a sample pad abutting the lateral flow assay test strip; a pinch wall positioned to direct fluid flow from the sample pad to the lateral flow assay test strip; a top support structure positioned on top of the test strip; and a bottom support structure positioned underneath the test strip, wherein each of the top and bottom support structures comprise a plurality of separate spaced-apart support ribs positioned along the length of the test strip. | 2010-09-09 |
20100226823 | Drying substances, preparation and use thereof - There is provided herein a dryer polymer substance adapted to pervaporate a fluid (such as water, water vapor or both), the polymer substance includes: a porous support member having a plurality of pores, wherein at least a portion of the pores are filled with a cross-linked co-polymer comprising (i) a cationic monomer and an anionic monomer, (ii) a zwitterionic monomer, or a combination thereof. The substance may include a membrane or a tube. There is further provided herein a process for the preparation of a dryer polymer substance adapted to pervaporate a fluid (such as water, water vapor or both), the process includes impregnating into at least a portion of the pores of a porous support member a solution which comprises: (i) a cationic monomer and an anionic monomer, (ii) a zwitterionic monomer, or a combination of (i) and (ii), graft co-polymerizing the anionic monomer and the cationic monomer and/or the zwitterionic monomer within at least a portion of the pores to form a co-polymer, and cross-linking the co-polymer, such that the pores of the support member are at least partially grafted with a cross-linked co-polymer bound to the support member. | 2010-09-09 |
20100226824 | Drying substances, preparation and use thereof - There is provided herein a dryer polymer substance comprising a polymer grafted with a compound having sulfonic groups, wherein the substance is adapted to pervaporate a fluid such as water, water vapor or both. There is further provided a process for the preparation of a dryer polymer substance adapted to pervaporate a fluid, the process includes processing a polymer into a desired form, activating at least a portion of the polymer, and grafting the activated portion of the polymer with a compound having groups adapted to be sulfonated. | 2010-09-09 |
20100226825 | Smart pipette with sensor in tip - The present invention relates to a pipette. More specifically, the invention relates to systems and methods for using the pipette. The pipette and system includes technological advancements which improve quality control and accuracy in pipetting operations. | 2010-09-09 |
20100226826 | SAMPLE COLLECTION DEVICE SUITABLE FOR LOW-VOLUME EXTRACTION - A sample collection device suitable for low-volume extraction includes a substantially tubular collection vessel having a closed end, an open end, and one or more sidewalls defining a vessel chamber having a vessel volume. The device further includes a swab for sample collection. The swab formed with a substantially closed-celled polymer foam head and the swab is configured for insertion into the collection vessel. | 2010-09-09 |
20100226827 | Sample cup for use in X-ray spectroscopy with internal overflow reservoir - A sample cup for retaining a sample material to be subjected to an x-ray spectrochemical analysis. The sample cup comprises a cell body of a cylindrical configuration having an open top end and an open bottom end and defining a hollow between the two open ends, the open top end having an outer wall and an inner wall encircling the open top end. The outer wall and the inner wall extend axially and are positioned in concentric relationship with one another and form a reservoir space therebetween. | 2010-09-09 |
20100226828 | TEST TUBE HOLDER - According to an example of the invention, a test tube holder includes a holder body including a cylindrical wall defining a cylindrical hollow portion, at least three guide grooves in the cylindrical wall and open on the inner peripheral side and upper end surface side, cam grooves which face the guide grooves and inclined obliquely upward, a plurality of holder members for test tube attachment which are fitted individually in the guide grooves of the holder body so as to be movable vertically and radially, cam pins which engage with the cam grooves so as to guide the holder member vertically and radially, and an urging spring which elastically urges the holder member to be pushed up so that the holder member is pressed upward and toward the inner periphery of the cylindrical wall. | 2010-09-09 |
20100226829 | HYDROGEN GENERATOR AND FUEL STICK - A hydrogen generator includes a plurality of fuel sticks each of which includes a hydrogen release compound configured to generate hydrogen by a chemical reaction, a pressure-resistant container configured to store therein the plurality of fuel sticks, and a controller configured to carry out control in such a manner that hydrogen is generated selectively from the plurality of fuel sticks. | 2010-09-09 |
20100226830 | PH ADJUSTING APPARATUS - A pH adjusting apparatus arranged above a water pit for refueling disposed in a reactor container that stores a nuclear reactor includes a pH adjuster, a basket | 2010-09-09 |
20100226831 | Plasma generating nozzle based on magnetron - The present invention provides a plasma generating system including a magnetron for generating microwave energy, a resonator attached to the magnetron and having a cavity to contain the microwave energy generated by the magnetron, and at least one nozzle secured to the resonator. The nozzle includes a housing having a generally cylindrical space formed therein, wherein the space forms a gas flow passageway; and a rod-shaped conductor disposed in the space and operative to transmit microwave energy along a surface thereof so that the microwave energy transmitting along the surface excites gas flowing through the space. A portion of the rod-shaped conductor extends into the cavity to capture the microwave energy in the cavity. The nozzle includes gas inlet structure configured to introduce gas into the cylindrical space to be excited into plasma | 2010-09-09 |
20100226832 | PROCESS FOR REGENERATING CATALYST FOR A HYDROCARBON CONVERSION ZONE - In one exemplary embodiment, a unit for regenerating a hydrocarbon conversion catalyst for a hydrocarbon conversion zone can generally include passing the hydrocarbon conversion catalyst through, sequentially, a catalyst-disengaging zone having a first atmosphere, an adsorption zone having a second atmosphere, and a regeneration zone including a combustion zone; introducing an inert gas between the first atmosphere and the second atmosphere; and passing a flue gas from the combustion zone to the adsorption zone. | 2010-09-09 |
20100226833 | Polyisocyanate production method and polyisocyanate production system - A polyisocyanate production method that can allow effective use of hydrogen chloride produced secondarily in a polyisocyanate production process, while allowing reduction of environmental burdens, and a polyisocyanate production system for performing the polyisocyanate production method. After chlorine is allowed to react with carbon monoxide to produce carbonyl chloride in a carbonyl chloride producing reactor, the carbonyl chloride produced in the carbonyl chloride producing reactor is allowed to react with polyamine in an isocyanate producing reactor to produce polyisocyanate. Then, after hydrochloric gas produced secondarily in the isocyanate producing reactor is purified in a hydrogen chloride purifying column, the purified hydrochloric gas is oxidized in a hydrogen chloride oxidizing reactor to produce chlorine. Thereafter, the chlorine thus produced is supplied to the carbonyl chloride producing reactor from a chlorine resupply line, so that it is allowed to react with carbon monoxide to produce carbonyl chloride. | 2010-09-09 |
20100226834 | Fuel reformer - A fuel reformer including a reaction container including a first chamber, a first reactor in the first chamber, the first reactor, including a first catalyst, being configured to produce a first reformate by performing a steam reforming reaction on a first fuel, and having a first gas hourly space velocity (GHSV) at a set flow rate, a first heat source thermally connected to the first reactor, and a second reactor connected to the first reactor, the second reactor including a second catalyst, being configured to produce a second reformate having a lower carbon monoxide content than the first reformate, and having a second GHSV greater than the first GHSV at the set flow rate. | 2010-09-09 |
20100226835 | METHOD AND APPARATUS FOR DISPENSING SOLID PRODUCT - A dispensing system includes a dispenser, a logic device, a nozzle, a diluent source, and a solid product. The logic device controls spray on and spray off cycles to pulse diluent supplied to the nozzle. The diluent contacts the solid product to dissolve a portion of the solid product and create a use solution. Pulsing the spray of diluent controls the concentration of the dispensed product in the use solution by limiting the amount of excess dilutant added to the dispensed product. The product is more consistently dispensed and the concentration of the dispensed product in the use solution is more consistent. Additionally, the concentration of the dispensed product in the use solution can be controlled by changing at least one of a volume of diluent dispensed through the nozzle, a pressure of diluent, a pulsed diluent spray frequency, and a pulsed diluent spray duration. | 2010-09-09 |
20100226836 | SANITIZER - A sanitizing device includes a base, a container supported by the base, a heating element supported by the base, and a blower assembly supported by the base. The container can include a base wall, a side wall, and a hot air inlet vertically offset above the base wall. The blower assembly can be situated with respect to the heating element and the hot air inlet to direct air over the heating element and through the hot air inlet into the container. | 2010-09-09 |
20100226837 | PRODUCTION OF METAL PRODUCTS DIRECTLY FROM UNDERGROUND ORE DEPOSITS - A process for producing metal compounds directly from underground mineral deposits including the steps of forming a borehole at a site into a mineral deposit containing metal compounds, inserting a slurry-forming device having a nozzle into the borehole adapted to direct pressurized water through the nozzle into the mineral deposit, supplying pressured water through the nozzle into the mineral deposit forming a mineral slurry containing metal compounds, extracting the mineral slurry containing metal compounds through the borehole, leaching the mineral slurry to convert the metal compounds to a soluble form in a leach solution, and removing metals and metal compounds by treating the leach solution with an extraction treatment adapted to remove the metal products. Steps of leaching the mineral slurry and removing metal products are performed at a location remote from the borehole site. Alternatively, the step of removing metal products from mineral slurry may be accomplished by pyrometallurgical processes. | 2010-09-09 |
20100226838 | PROCESS FOR THE REMOVAL OF CATALYST DEGRADATION PRODUCTS - The present invention relates to a process for the removal of metal catalyst degradation products from a bleed stream of a catalytic chemical reaction process, wherein the catalyst is based on a metal selected from those in group VIII of the periodic table, chromium, copper, molybdenum, tungsten, rhenium, vanadium, titanium and zirconium, said process comprising treatment of the bleed stream with an alkali metal carbonate or ammonium carbonate source to form a solid complex or an aqueous solution of said solid complex, and removal of the solid complex or the aqueous solution of said solid complex from the bleed stream. | 2010-09-09 |
20100226839 | Method For Recovery of Gallium - The present invention provides a novel process for the removal and recovery of gallium from a feed solution containing the gallium and copper. The process of the present invention utilizes a combination of a supported liquid membrane (SLM) and a strip dispersion to improve extraction of gallium while increasing membrane stability and decreasing processing costs. This novel process selectively removes gallium from feed solution containing the gallium and copper. | 2010-09-09 |
20100226840 | Removal of impurities in the production of crystalline sodium carbonate, bicarbonate, or sulfite - A magnesium treatment for removing water-soluble impurities in a process for making crystalline sodium carbonate, bicarbonate, or sulfite. A waste comprising such impurities is treated with a magnesium compound to form water-insoluble matter which is removed to form a purified solution. The treatment may be performed on a solution which contains the waste and optionally dissolved calcined trona. The purified solution may be used as a feedstock to form crystalline soda ash, and/or used as a reactant to produce crystalline sodium sulfite or bicarbonate via reaction with SO | 2010-09-09 |
20100226841 | PROCESS FOR SEPARATING OFF CARBON DIOXIDE - The present invention relates to a process for separating off carbon dioxide from gas mixtures by absorption using aqueous alkaline solutions, which comprises carrying out the absorption in a countercurrent flow apparatus in which the gas mixture which is to be worked up and the aqueous alkaline solution used are passed in countercurrent flow and wherein a discontinuous liquid phase forms in the interior of the countercurrent flow apparatus and the separation is carried out in the interior of the countercurrent flow apparatus in the presence of activated carbon, wherein the activated carbon is present in the interior of the countercurrent flow apparatus in an amount of 1 g to 2 kg of activated carbon per m | 2010-09-09 |
20100226842 | High Temperature Catalytic Process to Reduce Emissions of Carbon Monoxide - A method for oxidizing an amount of CO in a CO-containing gas stream, e.g., a combustion stream from fuel combustion, is provided. The method comprises exposing the CO-containing gas stream to a catalytic coating at reaction conditions, including least 8 vol. % and a temperature of at least 600° C. At these reaction conditions, the method comprises generating gaseous intermediate oxidizing species at the catalytic coating for oxidation of the carbon monoxide within the CO-containing gas stream as a homogeneous reaction to improve CO removal efficiency. | 2010-09-09 |
20100226843 | METHOD FOR PREPARING CERIUM CARBONATE AND METHOD FOR PREPARING CERIUM OXIDE POWDER - The present invention relates to a method for preparing cerium carbonate that can improve yield and productivity of cerium carbonate, cerium carbonate powder, and a method for preparing cerium oxide using the same. The method for preparing cerium carbonate comprises the steps of mixing a cerium precursor and urea; and, elevating the temperature of the mixture to 50˜250° C. under solvent free condition to react the cerium precursor and urea. | 2010-09-09 |
20100226844 | METHOD AND APPARATUS FOR PRODUCING GRANULAR SILICON - Silicon granules are produced by chemical vapor deposition on seed particles inside a chamber within a fluidized bed reactor. The chamber contains an obstructing member, or bubble breaker, which is sized and shaped to restrict the growth of bubbles inside the chamber and which has interior passageways through which a heated fluid passes to transfer heat to gas inside the chamber. | 2010-09-09 |
20100226845 | Mixed-Metal Oxides Precipitated With Supercritical CO2 - Hopcalite-type catalysts for oxidation of CO are formed by preparing a mixed-metal oxide precursor by firstly preparing a solution of a mixture of metal precursor compounds in a solvent, followed by contacting the solution with a supercritical antisolvent to precipitate the mixed-metal oxide precursor. A mixed-metal oxide may then be prepared from the precursor by oxidation, for example by calcination. The mixed-metal oxide is then collected and optionally activated for use as a catalyst. The activated or calcined catalyst contains a nano-structured mixed-phase composition comprising phase-separated intimately mixed nanoparticles of copper and manganese oxide. | 2010-09-09 |
20100226846 | SILVER AND SILVER OXIDE CATALYSTS FOR THE OXIDATION OF CARBON MONOXIDE IN CIGARETTE SMOKE - A component of a cigarette comprises a silver-based catalyst for the conversion of carbon monoxide to carbon dioxide. The silver-based catalyst comprises particles (e.g., nanoscale or larger sized particles) of metallic silver and/or silver oxide supported in and/or on metal oxide support particles. The silver-based catalyst can be incorporated into a cigarette component such as tobacco cut filler, cigarette paper and cigarette filter material to reduce the concentration of carbon monoxide in the mainstream smoke of a cigarette during smoking. The catalyst can also be used in non-cigarette applications. | 2010-09-09 |
20100226847 | Method for direct, chirality-selective synthesis of semiconducting or metallic single-walled carbon nanotubes - The present invention is a method comprising a direct chirality-selective nucleation and synthesis of single-walled carbon nanotubes from carbon-containing gases using catalytic nanoparticles of uniform size heated by ultra-short laser pulses of selected frequency to temperatures sufficient for carbon nanotube nucleation and synthesis. | 2010-09-09 |
20100226848 | Catalyst for Carbon Nanostructure Growth, Process for Producing Carbon Nanostructure, Raw-Material Gas and Carrier Gas for Producing the Same, and Apparatus for Producing the Same - It is the purpose of this invention to present a process for producing carbon nanostructure in which the mechanism of continuous carbon nanostructure growth can be optimized and a high-quality carbon nanostructure can be produced, a catalyst for carbon nanostructure growth which is for use in the production, a raw-material gas and a carrier gas for producing the same, and an apparatus for producing the same. The process for carbon nanostructure production, in which the length of the nanostructure can be continuously controlled comprises feeding a carrier gas and a raw-material gas to a reaction chamber ( | 2010-09-09 |
20100226849 | Semiconductor Nanocrystal Synthesis Using a Catalyst Assisted Two-phase Reaction - A method for producing a high yield of high quality, low size distribution, and size tunable semiconductor nanocrystals. The method produces III-V, II-VI, II-V, IV-VI, IV, ternary, quarternary, and quinary semiconductor nanocrystals (quantum dots) using a catalyst assisted two-phase reaction. | 2010-09-09 |
20100226850 | METHOD FOR PRODUCING TITANIUM OXIDE - An even titanium oxide film is economically formed on the surface of a substrate. To actualize the film formation, an aqueous titanium tetrachloride solution containing 0.1 to 17% by weight of Ti is applied in a film-like state on the surface of a heat resistant substrate. While the liquid film state is kept as it is, the aqueous titanium tetrachloride solution is heated to 300° C. or more and H | 2010-09-09 |
20100226851 | LOW TEMPERATURE PROCESS FOR PRODUCING NANO-SIZED TITANIUM DIOXIDE PARTICLES - A process for synthesizing nano-sized rutile, anatase, or a mixture of rutile and anatase TiO | 2010-09-09 |
20100226852 | CLK-PEPTIDE AND SLK-PEPTIDE - The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen type-IV with substantially greater affinity than to the native triple helical form of collagen type-IV. Methods utilizing such antagonists for therapeutic treatment of tumor growth, tumor metastasis or of restenosis also are described, as are methods to use such antagonists as diagnostic markers of angiogenesis in normal or diseased tissues both in vivo and ex vivo. The invention further describes methods for treating tumors using said antagonists in combination with radiation therapy and therapies comprising the antagonists and radiation treatment. | 2010-09-09 |
20100226853 | Fluorine-18 derivatives of dasatinib and uses thereof - Provided herein are [ | 2010-09-09 |
20100226854 | MHC Peptide Complexes and Uses Thereof in Infectious Diseases - Novel compounds carrying ligands capable of binding to counter receptors on relevant target cells are disclosed. The compounds possess a number of advantageous features, rendering them very suitable for a wide range of applications, including use as detection systems, detection of relevant target cells as well as a number of other methods. In particular, novel MHC complexes comprising one or more MHC molecules are disclosed. The affinity and specificity of the MHC-peptide complexes are surprisingly high. The possibility of presenting to the target cells a plurality of MHC-peptide complexes makes the MHC complexes according to the present invention an extremely powerful tool e.g. in the field of therapy and diagnosis. The invention generally relates to the field of therapy, including therapeutic methods and therapeutic compositions. Also comprised by the present invention is the sample-mounted use of MHC complexes and MHC multimers. | 2010-09-09 |
20100226855 | Rate-Controlled Oral Dosage Formulations - The present invention relates to a drug delivery system, in which a drug containing core, either alone or coated with a rate controlling membrane system, is enveloped on its circumference by an optionally bioadhesive coating, thereby yielding a monolithic system that allows for drug release in a regulated manner. | 2010-09-09 |
20100226856 | DYNAMIC BIO-NANOPARTICLE ELEMENTS - The invention in suitable embodiments is directed to dynamic bio-nanoparticle elements and bio-nanoparticle platforms employing such bio-nanoparticle elements. In one aspect, one or more elements of one or more types, formed from isolated, synthetic and or recombinant amino acid residues comprising in whole or in part one or more types of Clathrin and or Coatomer I/II proteins of one or more isoforms, execute one or more functions and or effect one or more ends, in vivo and or in vitro. | 2010-09-09 |
20100226857 | TUMOR CELL DIFFERENTIATION AGENTS AS CHEMICAL INHIBITORS AND TREATMENTS FOR INTRACELLULAR PARASITES - The present invention provides new compositions and methods for treatment of intracellular parasites. The compositions comprise one or more hydroxamic acids in an amount sufficient to interfere with the activity of one or more histone deacetylases in the intracellular parasites. The compositions and methods can be used to treat members of the Apicomplexa group of intracellular parasites. | 2010-09-09 |
20100226858 | METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION - The present invention describes an association between genetic polymorphisms in the ceramide kinase-like (CERKL) gene and a predisposition to prolongation of the QT interval, and provides related methods for the prediction of such a predisposition, the administration of QT interval-prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing QT prolongation. | 2010-09-09 |
20100226859 | 13C-MR IMAGING OR SPECTROSCOPY OF CELL DEATH - The invention relates to method of | 2010-09-09 |
20100226860 | NEUROMYELITIS OPTICA AUTOANTIBODIES AS A MARKER FOR NEOPLASIA - The present invention provides for methods and materials for diagnosing and treating neuromyelitis optica (NMO). | 2010-09-09 |
20100226861 | TOPICAL COMPOSITION DETECTION - Compositions, devices, methods, and kits are provided for determining the presence of topical compositions on surfaces, such as skin. | 2010-09-09 |
20100226862 | MICROCAPSULE AND METHOD FOR MAGNETIC RESONANCE IMAGING TO LOCALIZE BLOOD - Microcapsule for injection into the bloodstream of a patient before a magnetic resonance acquisition pertaining to the bloodstream, include a magnetic resonance marking substance (in particular with at least one isotope associated with a specific resonant frequency) inside the microcapsule and an outer membrane that is impermeable to the marking substance. The microcapsule is overall biodegradable. | 2010-09-09 |
20100226863 | HOMEOPATHIC MEDICAMENT USEFUL FOR IMMUNOMODULATION - Homeopathic immunomodulator medicament, auxiliary in the treatment of the immunolog Formula: formed by 1000 ml of the hydro-alcoholic solution, and variables of | 2010-09-09 |
20100226864 | ALKYL-SUBSTITUTED TETRAHYDROPYRANS AS FLAVORING SUBSTANCES - The present invention relates to alkyl-substituted tetrahydropyrans, mixtures containing these alkyl-substituted tetrahydropyrans, their respective use and corresponding flavored products. | 2010-09-09 |
20100226865 | TOOTHPASTE COMPOSITION - A toothpaste composition comprising a surfactant, an abrasive, a humectant, triglyceride oil, a carboxylated polysaccharide, and a sulphated or sulphonated polysaccharide and the use of a sulphated or sulphonated polysaccharide, in particular a carrageenan, to improve the in-use foam quality of a toothpaste. | 2010-09-09 |
20100226866 | SOLID PREPARATION FOR ORAL APPLICATION - Provided is a solid preparation for oral application containing (a) gum tragacanth and (b) a polyphosphoric acid or salt thereof and constituted so that the polyphosphoric acid or salt thereof starts to dissolve firstly and the gum tragacanth starts to dissolve subsequently. The solid preparation for oral application according to the present invention has a high plaque formation inhibiting effect. | 2010-09-09 |
20100226867 | NON-IRRITATING COMPOSITIONS - The present invention provides a base composition that allows for the formulation of non-irritating cosmetic and/or dermatological compositions. The base composition includes one or more of electrolyte, buffer, mild preservative, lubricant, or any combinations thereof. It is preferred that one or more of the above components are eye-safe and/or eye-compatible. The present invention also provides photoprotective cosmetic and/or dermatological compositions that include the base composition and one or more sunscreen active components and are non-irritating to mammalian eyes. | 2010-09-09 |
20100226868 | AMPHOLYTIC TER-POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS - Novel ampholytic ter-polymers comprising at least an ethylenically unsaturated cationic monomer, a monomer containing a carboxylic acid or sulfonic acid group and diallyamine or derivative are claimed. Further, the ter-polymers may be used in personal care or personal washing compositions optionally in the presence of conditioning agents such as silicone, fatty amines, fatty amine oxides and fatty quaternaries and/or various benefit agents. The ter-polymer compositions are especially useful in the treatment of keratin-containing substrates. Keratin substrates include, but are not limited to, animal and human hair, skin and nails. | 2010-09-09 |
20100226869 | LUSTROUS AND SCRATCH-RESISTANT NAIL VARNISH THROUGH ADDITION OF SOL-GEL SYSTEMS - The present invention relates to, for example, a nail varnish additive, a nail varnish additive composition for improving at least one property of nail varnishes, the nail varnish additive composition being, in one embodiment, in the form of a sol-gel system; to a process for forming a nail varnish additive composition; to a process for forming a nail varnish comprising a nail varnish additive composition; to a nail varnish comprising a nail varnish additive composition; to a process for forming a laminate comprising a nail and the nail varnish additive composition; and to a laminate comprising a nail and the nail varnish additive. | 2010-09-09 |
20100226870 | USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION - The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate, cyclocreatine, 3 guanidinopropionic acid, guanidinoacetate, homocyclocreatine, guanidino benzoates as energy generating systems and antioxidants for preservation of skin against adverse aging effects and damage secondary to insults such as harmful sun radiations, stress and fatigue. The creatine compounds which can be used in the present method include (1) creatine, creatine phosphate and analogs of these compounds which can act as substrates or substrate analogs for creatine kinase; (2) molecules that mimic the biological activity of creatine (3) molecules that modulate the creatine kinase system. | 2010-09-09 |
20100226871 | HIGH INTENSITY FRAGRANCES - The present invention relates to a high intensity fragrance composition for use in a cosmetic, toiletry, personal care, personal cleansing product or adsorbent article, which comprises by weight: a) 75% to 100% of at least 2 fragrance ingredients where each fragrance ingredients must contain only atoms of carbon, hydrogen, oxygen and nitrogen, comprise an ester functional group, an alcohol functional group or an aldehyde functional group, have boiling points between 100° C. and 300° C. at a pressure of 760 mm of mercury, have molecular weights within the range of 70 atomic mass units to 175 atomic mass units, and have ClogP values between 0.00 and 4.00; b) 0 to 25% of an essential oil; and c) 0 to 25% of a fragrance ingredient other than the fragrance ingredients in category a), wherein the sum of a), b) and c) equals 100%. | 2010-09-09 |
20100226872 | Stabilized Liquid Preservative Compositions - The present invention is a directed to a composition and method of solubilizing and stabilizing a liquid preservative composition containing an alkyl paraben ingredient which comprises including polyvinyl pyrrolidone (PVP) in said composition. The compositions are particularly useful in personal care products. | 2010-09-09 |
20100226873 | Hemostatic Composition with Magnetite - A composition and method of arresting the flow of blood from a bleeding wound. The composition preferably includes an anhydrous salt ferrate compound preferably combined with an effective amount of an insoluble cation exchange material and an effective amount of anhydrous Magnetite mixed uniformly together. Povidone iodine may be added for enhanced antimicrobial properties. In the method, a quantity of the composition is magnetically attached to a surface of a magnet, after which the powderous mixture is applied to the wound by pressing the surface covered with the powderous compound against the wound for a time sufficient to clot the blood to arrest substantial further blood flow from the wound. | 2010-09-09 |
20100226874 | BIOCIDAL COMPOSITIONS - Embodiments of the present subject matter provide a biocidal composition comprising an aqueous mixture of (a) a phosphonium compound and (b) a polymeric ammonium compound, wherein the weight ratio of compound (a) to compound (b) is from 0.2:1 to 20:1, and wherein
| 2010-09-09 |
20100226875 | CONTROLLED RELEASE OF ACTIVE COMPOUNDS FROM DYNAMIC MIXTURES - The present invention relates to a dynamic mixture in the form of a dynamic mixture obtained by reacting together, in the presence of water, at least one O-substituted hydroxylamine or S-substituted thiohydroxylamine derivative with at least one perfuming, flavoring, insect repellent or attractant, bactericide or fungicide aldehyde or ketone. This mixture is capable of releasing in a controlled and prolonged manner the aldehyde or ketone into the surrounding environment. Furthermore, the present invention concerns also the use of these dynamic mixtures as perfuming ingredients as well as the perfuming compositions or perfumed articles that include these mixtures. | 2010-09-09 |
20100226876 | COMPOSITION FOR CONTROLLING FISH - The present invention relates to a composition for controlling fish. In particular, the composition may be an incitant, functioning as either a fish attractant or a fish repellent. The composition may be prepared by extracting bacteria from a source fish, culturing the bacteria in an appropriate media, and subsequently combining the cultured bacteria with a substrate to form the composition. | 2010-09-09 |
20100226877 | Semiochemical - cis-Jasmone has been discovered to be useful as a semiochetnical that changes the behaviour of insects and/or the physiology of plants. It has direct signalling roles with plant-feeding aphids, in attraction of aphid predators and parasitoids, and may act as an airborne signal inducing production of volatile plant semiochemicals, including the monoterpene (E)-β-ocimene, that stimulate foraging by parasitoids. It is an extremely benign compound having, to human beings, a pleasant aroma and gives a long-lasting effect after removal of the stimulus. | 2010-09-09 |
20100226878 | METHODS OF INHIBITING PHOTORECEPTOR APOPTOSIS - The present invention provides methods to prevent photoreceptor death. In particular, the present invention provides peptides which prevent FAS-mediated photoreceptor apoptosis. | 2010-09-09 |
20100226879 | HETEROCYCLIC ANTIVIRAL COMPOUNDS - Compounds having the formula A-R wherein A is a hetereoaryl and R is Ia, Ib or Ic and wherein A, R, R | 2010-09-09 |
20100226880 | TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents. | 2010-09-09 |
20100226881 | PYRAZOLO[1,5-a]PYRIDINES AND THEIR USE IN CANCER THERAPY - Pyrazolo[1,5-a]pyridines are described, including methods for their preparation, and their use as agents or drugs for cancer therapy, both alone or in combination with radiation and/or other anticancer drugs. | 2010-09-09 |
20100226882 | LINKED DIIMIDAZOLE ANTIVIRALS - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: | 2010-09-09 |
20100226883 | LINKED DIIMIDAZOLE DERIVATIVES - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: | 2010-09-09 |
20100226884 | Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R) - The present invention provides compositions and methods of use of anti-IGF-1R antibodies or antibody fragments. Preferably the antibodies bind to IGF-1R but not IR; are not agonists for IGF-1R; do not block binding of IGF-1 or IGF-2 to isolated IGF-1R, but effectively neutralize activation of IGF-1R by IGF-1 in intact cells; and block binding of an R1 antibody to IGF-1R. The antibodies may be murine, chimeric, humanized or human R1 antibodies comprising the heavy chain CDR sequences DYYMY (SEQ ID NO:1), YITNYGGSTYYPDTVKG (SEQ ID NO:2) and QSNYDYDGWFAY (SEQ ID NO:3) and the light chain CDR sequences KASQEVGTAVA (SEQ ID NO:4), WASTRHT (SEQ ID NO:5) and QQYSNYPLT (SEQ ID NO:6). Preferably the antibodies bind to an epitope of IGF-1R comprising the first half of the cysteine-rich domain of IGF-1R (residues 151-222). The anti-IGF-1R antibodies may be used for diagnosis or therapy of various diseases such as cancer. | 2010-09-09 |
20100226885 | METHOD OF TREATING HEPATITIS C PATIENTS - This application discloses a novel method of identifying patients amongst treatment naïve patients suffering from HCV infection that are amenable to treatment with a protease inhibitor. The application also discloses a method of treating treatment naïve, nonresponder and relapsed patients suffering from an HCV infection. | 2010-09-09 |
20100226886 | Combinations of MTP Inhibitors with Cholesterol Absorption Inhibitors or Interferon for Treating Hepatitis C - The invention is directed in part to methods for treating and/or controlling hepatitis C in a patient. The methods are directed in part to combination therapies using a microsomal triglyceride transfer protein (MTP) inhibitor (for example, AEGR-733 and implitapide) and at least one other active agent. | 2010-09-09 |
20100226887 | BETA-2-GLYCOPROTEIN 1 IS AN INHIBITOR OF ANGIOGENESIS - The present disclosure provides a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked β2-Glycoprotein 1 (βGP1) to cells associated with the tissue. The presence of β2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. The disclosure also provides a method for treating tumors by providing β2GP1 to the tumor. | 2010-09-09 |
20100226888 | Ethanol Enhances the Complete Replication of Hepatitis C Virus: the Role of Acetaldehyde - Methods are provided for inhibiting replication of an RNA virus in a cell infected with the virus, wherein the cell is characterized as having been or concurrently being exposed to a physiologically relevant concentration of a compound selected from ethanol, acetate, isopropanol, acetaldehyde or acetone, comprising contacting the cell with an effective amount of one or more of a HMG-CoA reductase inhibitor, a fatty acid biosynthesis inhibitor, thyroxine, or an agent promoting clearance of the compound from a cell. Also provided are methods to treat a subject having one or more cells characterized as having a physiological concentration of ethanol, acetate, isopropanol, acetaldehyde or acetone, in particular subjects that suffer chronic alcoholics, diabetes or starvation. | 2010-09-09 |
20100226889 | HCV Combination Therapies - The invention relates to combination therapies for the treatment of hepatitis C virus with telaprevir and pegylated interferon alfa-2a with or without ribavirin. The invention relates to the treatment of Latino and African American patients infected with HCV using the combination therapy. | 2010-09-09 |
20100226890 | Bacteriophage and their uses - There is provided a bacteriophage capable of lysing a | 2010-09-09 |
20100226891 | SURFACE EXPRESSION VECTOR FOR FUSION PROTEIN OF MYO-2 PEPTIDE MULTIMER AND MYOSTATIN, AND MICROORGANISM TRANSFORMED BY THEREOF - The present invention relates to a fusion protein in which a myostatin mature protein is fused to a multimer of myostatin-derived antigenic peptide Myo-2, a surface expression vector containing a polynucleotide encoding the fusion protein, a recombinant microorganism transformed with the vector, and a feedstuff additive or a pharmaceutical composition containing the microorganism as an effective ingredient. The feedstuff additive or pharmaceutical composition according to the present invention can be used for muscle development and regulation of muscle growth in livestock and poultry, as well as for preventing and treating muscle-wasting diseases and degenerative diseases such as muscular dystrophy, muscular atrophy and the like. In addition, the transformed strain shows the same effect even if the strain itself after culture thereof is directly used, and thus it is very economical. | 2010-09-09 |
20100226892 | USE OF PROBIOTIC MICROORGANISMS TO LIMIT SKIN IRRITATION - Disclosed are methods directed to the cosmetic use of an effective amount of at least one probiotic microorganism especially from the genus | 2010-09-09 |
20100226893 | High Retention Cell Injectate - The present disclosure generally relates to high retention cell injectates, methods of producing the high retention cell injectates and further to methods of treating diseases or conditions by administering the cell injectates to patients in need thereof. To allow for cell rentention into a provided hyaluronic acid solution, the present disclosure provides pretreatment of cells with one or more substances that increases the number of CD44 receptors on their surfaces. Cells expressing CD44 ligands show increase in binding to hyaluronic acid. The pretreated cells are thus incorporated into hyaluronic acid. | 2010-09-09 |
20100226894 | Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood - Disclosed is a method to recover a mixture cell population consisting of a complete profile of progenitor cells including embryonic like stem cells (a “complete progenitor cell mixture” or CPM) from the peripheral blood of an individual by administering to that individual a combination of at least one or more from the category of growth factors and hormones combining with at least one or more from the category of cell fusion inhibitor compounds, and then recovering peripheral blood progenitor cells from said individual. The hormones and growth factors group should include hGH (human growth hormone) with or without erythropoietin (EPO), but specifically without either G-CSF or GM-CSF. The cell fusion inhibitor group should include a CXCR4 antagonist. Also disclosed is a method for using or preserving such a complete progenitor cells mixture (CPM) for the treatment of diseases. | 2010-09-09 |
20100226895 | NEURAL SCAFFOLDS - Disclosed herein are compositions and methods useful for preparing neural scaffolds. The scaffolds comprise tissue taken from the spinal cord and/or dura mater of vertebrate and can be processed to form gels or sheets. Methods of treating patient with CNS injury are also presented. | 2010-09-09 |
20100226896 | METHOD FOR INTRATHECAL ADMINISTRATION OF AUTOLOGOUS STEM CELLS IN PREMATURE INFANTS - The invention provides a method of treating a premature infant at a statistical risk of sustaining an intraventricular hemorrhage. The method, or therapeutic protocol, can include at least one or more of the following steps: identifying premature infants at a statistical risk of having an intraventricular hemorrhage, collecting umbilical cord blood from the identified premature infant, separating totipotential stem cells (e.g., having the ability to proliferate and differentiate as neural stem cells) from the collected cord blood, storing the separated stem cells, establishing evidence of an intraventricular hemorrhage (preferably prior to Grade III/IV if possible) in the premature infant, and intrathecally administering the autologous cord blood derived stem cells to the premature infant. | 2010-09-09 |
20100226897 | METHOD FOR MODIFYING THE WETTABILITY AND/OR OTHER BIOCOMPATIBILITY CHARACTERISTICS OF A SURFACE OF A BIOLOGICAL MATERIAL BY THE APPLICATION OF GAS CLUSTER ION BEAM TECHNOLOGY AND BIOLOGICAL MATERIALS MADE THEREBY - The invention provides methods for surgical grafting of a tissue. The method comprises the steps of explanting a graft tissue from a donor, irradiating at least a first portion of the graft tissue with an ion beam, and surgically grafting the graft tissue into a recipient. | 2010-09-09 |
20100226898 | COMPOSITIONS AND METHODS FOR ENGRAFTMENT AND INCREASING SURVIVAL OF ADULT MUSCLE STEM CELLS - Embodiments herein relate to compositions and methods for engraftment of and increasing survival of muscle cells in a subject in need thereof. In certain embodiments, compositions including myofibers and/or satellite stem cells may be administered to a subject. Other embodiments relate to compositions and methods for introducing one or more compounds to a subject using cell compositions disclosed herein. Still other embodiments relate to uses of these compositions in kits for portable applications and methods. | 2010-09-09 |
20100226899 | Categorization of Microbial Communities - The present disclosure provides embodiments of a method for characterizing microbial populations. Exemplified by methods for characterizing microbiota in vaginal samples, the methods provided herein are widely applicable to the characterization of microbial communities. Also provided are probiotic regimens and methods for selecting appropriate probiotic regimens based on the normal vaginal microbiota of a subject. Reagents and kits for detecting normal vaginal microbiota and diagnosing pathogenic microorganisms in the vagina are also provided. | 2010-09-09 |
20100226900 | PREVENTION AND TREATMENT OF OSTEOCHONDROSIS IN ANIMALS AND HUMANS - The invention provides compositions and methods for preventing and treating osteochondrosis and lameness by administration of supplemental boron containing compounds to animals and humans. The supplemental boron containing compounds are provided in animal feed compositions or as supplements for animal feed. Also provided by this invention are animal feed compositions that are supplemented with boron containing compounds and which have reduced phosphorus content. The invention also provides a method for decreasing the amount of phosphorus excreted by an animal, a method of increasing the efficiency of absorption of phosphorus by an animal, a method of reducing environmental phosphorus pollution by administering supplemental boron to the animal. The invention also provides a method of reducing pre-weaning mortality in an animal by feeding pregnant, nursing or lactating animals by administering supplemental boron containing compounds. | 2010-09-09 |
20100226901 | GENETIC CONTROL OF MAMMALIAN CELLS WITH SYNTHETIC RNA REGULATORY SYSTEMS - The present application relates to nucleic acids that encode a RNA switch responsive to a ligand that can control the expression of a gene product that affects the cell fate determination of a mammalian cell are provided. In some embodiments, the system can be used to control the proliferation or activation of mammalian cells in response to a ligand that can be provided exogenously to the mammalian cell or can be produced by the mammalian cell. The system can be used to promote the growth or proliferation of human T cells in response to an exogenous ligand applied to the cells. In one embodiment, the system detects the ligand through a RNA aptamer that modulates expression of a gene product through activation or inactivation of a ribozyme that modulates expression of the gene product. | 2010-09-09 |
20100226902 | Method For Treating Wounds With Enriched Platelet Wound Healant - An improved method for treating wounds with an enriched platelet composition is provided in which a small amount of a patient's blood is used to prepare, at point-of-care, a platelet-rich plasma (PRP) from which a gel is produced. The method involves the use of improved materials to improve the ease and speed at which wounds may be treated at the point-of-care. | 2010-09-09 |
20100226903 | METHOD OF DELIVERING CELL THERAPY TO A TARGET SITE - A method of delivering therapy to a target site. The method includes (a) obtaining a base image of the target site, (b) injecting a dose of a mix of a therapeutic agent and a contrast agent into a first injection location at the target site via a needle passing through a catheter, (c) collecting sequential fluoroscopic images of a contrast agent dispersion cloud at the first injection location, (d) determining a contrast agent dispersion area from the sequential fluoroscopic images, (e) determining a therapeutic agent dispersion area from the contrast agent dispersion area, (f) marking the therapeutic agent dispersion area on the base image of the target site, and (g) repeating (b) through (f) until the target site is substantially covered with overlapping therapeutic agent dispersion areas corresponding to a plurality of injections at a plurality of injection locations at the target site. | 2010-09-09 |
20100226904 | ORGANIC CHEWABLE SUPPLEMENT - An organic chewable composition for delivering dietary supplements and pharmaceutical compounds. The chewable composition includes an organic delivery vehicle and an active ingredient. The delivery vehicle may include an organic gummy candy. The active ingredient may include an over-the-counter drug or a prescription drug to provide a desired effect on the user. The active ingredient may also include any combination of nutraceuticals, vitamins, minerals, antioxidants, soluble and insoluble fiber, herbs, plants, amino acids, and digestive enzymes. | 2010-09-09 |
20100226905 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RESTENOSIS COMPRISING PEROXIREDOXIN 2 PROTEIN AS AN ACTIVE INGREDIENT AND COMPOSITION FOR SCREENING THERAPEUTICS OF RESTENOSIS COMPRISING PEROXIREDOXIN 2 GENE OR ITS PROTEIN PRODUCT, AND METHOD FOR SCREENING TH - Disclosed herein is a pharmaceutical composition for the prophylaxis and treatment of restenosis, comprising a peroxiredoxin 2 (Prx II) protein as an active ingredient. Optionally, the composition may contain other active ingredients suppressive of restenosis at the carotid artery, the coronary artery, the peripheral artery, and the renal artery. Also, a composition and a method are provided for screening therapeutics for restenosis. This screening composition comprises a peroxiredoxin 2 gene or protein. Together with the method, the composition is useful for searching and developing therapeutics for restenosis. | 2010-09-09 |
20100226906 | Recombinant poly-glutamic acid depolymerases - In this application is described isolated, recombinant CapD and recombinant PghP for use in digesting capsule comprising polyglutamate polymers and for treatment of infections caused by bacilli having a polyglutamate capsule, such as anthrax. | 2010-09-09 |
20100226907 | PURIFICATION OF BUTYRYLCHOLINESTERASE USING MEMBRANE ADSORPTION - The present invention relates to purification of butyrylcholinesterase using anion exchange material, where the butyrylcholinesterase content is enriched at least 10 fold per total protein in the composition. | 2010-09-09 |